Abstract

COMPARATIVE CLINICAL EVALUATION OF VIRECHANA KARMA & EDAGAJADI LEPA IN VICHARCHIKA (ECZEMA)

Swati Rawat*, Pravesh Kumar Mukeriya, Sanjay Gupta and Nitesh Anand

ABSTRACT

Kushtha has been taken as the supreme word for all skin diseases in Ayurveda which is further classified as Maha Kushtha and Kshudra Kushtha. Vicharchika is mentioned under Kshudra Kushtha characterized with symptoms namely Kandu, Pidika, Srava, Shyavata, Rukshata. It bears greater resemblance with eczema, which is defined as non-contagious inflammatory response of skin to multiple agents, characterized by erythema, edema, vesiculation, oozing, crusting and later lichenification. Eczema affects 15-20% of children and 1-3% of adults worldwide. Its point prevalence in India is 6.75%. It is chronic in nature, difficult to treat and even after being cured there are chances of re-occurrence. Ayurveda is contributing remarkably because of its unique approach like Shodhana, Shamana and Nidana Parivarjana are the main factor of treatment. Hence, with the aim of identifying and establishing an alternative, safer, effective and long-lasting treatment modality, the study entitled “Comparative Clinical Evaluation of Virechana Karma & Edagajadi Lepa in Vicharchika (Eczema)” was conducted in 40 patients. They were selected on the basis of standard inclusion and exclusion criteria and randomly allocated to two different treatment groups; Group- A (Virechana Karma with Trivrita Avaleha along with Triphala Kwatha) and Group- B (Edagajadi Lepa for local application). Total duration of the treatment was of 62 days along with a follow up period of 30 days. Both the interventions were effective, but in overall improvement of the patients “Group A” had better results than “Group B”. For better scientific validation, further research studies and clinical trials should be carried out with large sample size and longer duration of treatment.

Keywords: overall improvement of the patients “Group A” had better results than “Group B”. For better scientific validation, further research studies and clinical trials should be carried out with large sample size and longer duration of treatment.